Manmohan (Hrsg.) Singh

Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies

Buch

Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies takes a current look at the strategies, successes and challenges involved with the development of novel formulations of biologics, vaccines and cancer therapy. This thorough reference on the latest trends in the development of diverse modalities will appeal to a broad community of scientists, students and clinicians. Written by leading authors across academia and industry, this book covers important topics such as unique drug delivery devices, non-parenteral delivery trends, novel approaches to the treatment of cancer, immunotherapy and more. It includes real-world c… Mehr

CHF 224.00

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen

V106: Fremdlagertitel. Lieferzeit unbestimmt

Produktdetails

Weitere Autoren: Salnikova, Maya (Hrsg.)

ISBN: 978-0-12-416603-5
EAN: 9780124166035
Produktnummer: 17192312
Verlag: Academic Pr Inc
Sprache: Englisch
Erscheinungsjahr: 2015
Seitenangabe: 520 S.
Masse: H28.7 cm x B18.9 cm x D2.7 cm 1'213 g
Gewicht: 1213

Über den Autor

Manmohan Singh, Ph.D. is a well-known expert in the area of vaccine formulations and adjuvant research and has been working in vaccine R&D for the last 20 years. He has authored over 120 peer reviewed manuscripts, review articles and book chapters in this area. Dr. Singh is on the editorial board of 9 International Journals . He is also the editor of several books on vaccine delivery systems and adjuvants. He is currently working as the Head of Global Drug Product Development at Novartis Vaccines in Holly Springs, NC, U.S.A. Maya Salnikova, Ph.D. is a well-known expert in the area of biologics, biosimilars and vaccine formulations. She has been working on development of novel formulations for the past 10 years in academia and industry. She has authored over 20 peer reviewed articles and book chapters. Dr. Salnikova is on the board of reviewers for Journal of Pharmaceutical Sciences and has contributed in organizing of international conferences. She is currently working as Drug Product Development Lead at Novartis Vaccines in Holly Springs, NC, U.S.A.